PTH and osteoporosis: Parathyroid hormone (PTH) is a major research topic in increasing bone mass, and it is the only anabolic bone therapeutic option approved by the Food and Drug Administration (FDA) for patients with low bone mass conditions, such as osteoporosis, to date [6–9].